Stock Scorecard
Stock Summary for Inovio Pharmaceuticals Inc (INO) - $1.96 as of 8/22/2025 8:14:28 PM EST
Total Score
8 out of 30
Safety Score
30 out of 100
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for INO
| Positive Quarterly and Annual earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the Annual earnings growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for INO
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for INO
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 | |
| Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for INO
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Safety Rating Criteria for INO (30 out of 100)
| Stock Price Rating (Max of 10) | 2 |
| Historical Stock Price Rating (Max of 10) | 9 |
| Stock Price Trend (Max of 10) | 1 |
| Book Value (Max of 10) | 1 |
| Book Value to Price (Max of 10) | 0 |
| Analyst Buy Ratings (Max of 5) | 3 |
| Analyst Strong Buy Ratings (Max of 5) | 4 |
| Dividend Yield Percentage (Max of 10) | 0 |
| Operating Margin (Max of 10) | 0 |
| Trading Volume (Max of 10) | 10 |
| Price to Earnings (Max of 10) | 0 |
| Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) | 0 |
Latest News for for INO
Financial Details for INO
Company Overview |
|
|---|---|
| Ticker | INO |
| Company Name | Inovio Pharmaceuticals Inc |
| Country | USA |
| Description | Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA drugs to treat and protect people from diseases associated with the human papillomavirus (HPV), cancer, and infectious diseases. |
| Sector Name | LIFE SCIENCES |
| Industry Name | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
| Most Recent Quarter | 6/30/2025 |
| Next Earnings Date | N/A |
Stock Price History |
|
| Last Day Price | 1.96 |
| Price 4 Years Ago | 59.88 |
| Last Day Price Updated | 8/22/2025 8:14:28 PM EST |
| Last Day Volume | 2,280,347 |
| Average Daily Volume | 1,851,143 |
| 52-Week High | 7.76 |
| 52-Week Low | 1.30 |
| Last Price to 52 Week Low | 50.77% |
Valuation Measures |
|
| Trailing PE | N/A |
| Industry PE | 40.71 |
| Sector PE | 58.53 |
| 5-Year Average PE | -12.68 |
| Free Cash Flow Ratio | 4.26 |
| Industry Free Cash Flow Ratio | 39.45 |
| Sector Free Cash Flow Ratio | 30.30 |
| Current Ratio Most Recent Quarter | 1.66 |
| Total Cash Per Share | 0.46 |
| Book Value Per Share Most Recent Quarter | 0.78 |
| Price to Book Ratio | 3.61 |
| Industry Price to Book Ratio | 4.94 |
| Sector Price to Book Ratio | 26.66 |
| Price to Sales Ratio Twelve Trailing Months | 539.19 |
| Industry Price to Sales Ratio Twelve Trailing Months | 4.40 |
| Sector Price to Sales Ratio Twelve Trailing Months | 13.25 |
| Analyst Buy Ratings | 2 |
| Analyst Strong Buy Ratings | 2 |
Share Statistics |
|
| Total Shares Outstanding | 53,143,000 |
| Market Capitalization | 104,160,280 |
| Institutional Ownership | 19.26% |
Dividends |
|
| Ex-Dividend Date | N/A |
| Previous Dividend Amount | 0.0000 |
| Current Dividend Amount | 0.0000 |
| Total Years Dividend Increasing | N/A |
| Trailing Annual Dividend Rate | 0.00 |
| Trailing Annual Dividend Yield | 1.52% |
| Forward Annual Dividend Rate | 0.00 |
| Forward Annual Dividend Yield | 0.00% |
| 5-Year Dividend Payments Count | 0 |
| 3-Year Average Dividend Yield | 0.00% |
| 5-Year Average Dividend Yield | 0.00% |
| 1-Year Dividend Growth Rate Percentage | 0.00% |
| 3-Year Dividend Growth Rate Percentage | 0.00% |
| 5-Year Dividend Growth Rate Percentage | 0.00% |
| All-Time Dividend Growth Rate Percentage | 0.00% |
| Dividend Payout Ratio | N/A |
Income Statement |
|
| Quarterly Earnings Growth YOY | 0.00% |
| Annual Earnings Growth | 20.62% |
| Reported EPS 12 Trailing Months | -2.59 |
| Reported EPS Past Year | -1.12 |
| Reported EPS Prior Year | -3.99 |
| Net Income Twelve Trailing Months | -87,761,266 |
| Net Income Past Year | -107,254,126 |
| Net Income Prior Year | -135,117,352 |
| Quarterly Revenue Growth YOY | 14.00% |
| 5-Year Revenue Growth | -44.44% |
| Operating Margin Twelve Trailing Months | -52,569.00% |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 24,351,377 |
| Total Cash Past Year | 65,813,297 |
| Total Cash Prior Year | 14,310,862 |
| Net Cash Position Most Recent Quarter | 7,580,723 |
| Net Cash Position Past Year | 49,042,643 |
| Long Term Debt Past Year | 16,770,654 |
| Long Term Debt Prior Year | 16,770,654 |
| Total Debt Most Recent Quarter | 16,770,654 |
| Equity to Debt Ratio Past Year | 0.80 |
| Equity to Debt Ratio Most Recent Quarter | 0.63 |
| Total Stockholder Equity Past Year | 68,503,795 |
| Total Stockholder Equity Prior Year | 117,349,129 |
| Total Stockholder Equity Most Recent Quarter | 28,530,905 |
Free Cash Flow |
|
| Free Cash Flow Twelve Trailing Months | -47,789,983,718 |
| Free Cash Flow Per Share Twelve Trailing Months | -899.27 |
| Free Cash Flow Past Year | -104,564,385 |
| Free Cash Flow Prior Year | -124,686,449 |
Options |
|
| Put/Call Ratio | 1.80 |
| Has Options | Options Chain |
| Liquidity Rating | |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | 0.07 |
| MACD Signal | 0.01 |
| 20-Day Bollinger Lower Band | 1.22 |
| 20-Day Bollinger Middle Band | 1.77 |
| 20-Day Bollinger Upper Band | 2.33 |
| Beta | 1.39 |
| RSI | 63.61 |
| 50-Day SMA | 2.88 |
| 150-Day SMA | 8.18 |
| 200-Day SMA | 16.78 |
System |
|
| Modified | 8/21/2025 2:59:53 AM EST |